Form D · Hedge Fund

Sofinnova BioEquities, LP

Menlo Park, CA · CIK 0001706472

Offering snapshot reported May 8, 2026 · SEC filing

Reported sold: $377M
Investors reported: 77
Minimum accepted: $0
First sale: Jan 3, 2017

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$363,726,521 → $376,921,569
Reported investors74 → 77

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 8, 2026	Amendment	$376,921,569	$13,195,048vs May 9, 2025	77	SEC filing
May 9, 2025	Amendment	$363,726,521	$3,222,645vs May 9, 2024	74	SEC filing
May 9, 2024	Amendment	$360,503,876	$2,610,018vs May 9, 2023	67	SEC filing
May 9, 2023	Amendment	$357,893,858	$26,979,858vs May 9, 2022	65	SEC filing
May 9, 2022	Amendment	$330,914,000	-$2,197,000vs May 14, 2021	59	SEC filing
May 14, 2021	Amendment	$333,111,000	$184,857,719vs May 15, 2020	55	SEC filing
May 15, 2020	Amendment	$148,253,281	$65,758,258vs May 15, 2019	46	SEC filing
May 15, 2019	Amendment	$82,495,023	$58,745,023vs May 15, 2018	38	SEC filing
May 15, 2018	Amendment	$23,750,000	$13,405,000vs May 15, 2017	32	SEC filing
May 15, 2017	Initial	$10,345,000	No comparison	18	SEC filing

Offering details

Securities: Equity, Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0 (estimated)
Form D file number: 021-286773

Source: Form D, filed May 8, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.

Matched by reported Form D file number

SOFINNOVA BIOEQUITIES MASTER FUND, LTD.

Investment adviser: SOFINNOVA INVESTMENTS, INC.

Gross asset value: $121M
Beneficial owners: 50
ADV minimum commitment: $3M

Reported in Form ADV on Mar 27, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CITCO FUND ADMINISTRATION (CAYMAN ISLANDS) LIMITED GRAND CAYMAN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →

Auditor KPMG, LLP SAN FRANCISCO, California, United States Other funds reporting this name →

Custodian BNY MELLON TRUST COMPANY (IRELAND) LIMITED DUBLIN, Ireland Related to adviser: No Other funds reporting this name →

Custodian CITCO BANK CANADA TORONTO, Canada Related to adviser: No Other funds reporting this name →

Custodian EQUINITI TRUST COMPANY, LLC NEWARK, New Jersey, United States Related to adviser: No Other funds reporting this name →

Custodian GOLDMAN SACHS & CO. LLC SAN FRANCISCO, California, United States Related to adviser: No Other funds reporting this name →

See filing for more → Showing the first 6 providers by role and name. IAPD may show a newer filing.

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

KPMG, LLP
PCAOB 185

EQUINITI TRUST COMPANY, LLC
LEI 213800YI5RL9BRL4V892

GOLDMAN SACHS & CO. LLC
SEC 8-129

Fund asset history · 5 annual observations

Scroll to see all columns →

Fiscal year	Gross assets	Beneficial owners	ADV filed
2021	$788,383,495	43	Mar 30, 2022
2022	$212,954,689	56	Mar 29, 2023
2023	$203,648,063	50	Mar 15, 2024
2024	$172,013,678	54	Mar 20, 2025
2025	$121,449,541	50	Mar 27, 2026

Filing source

Form ADV 2075659 · Mar 27, 2026 · Schedule D 7.B.(1), fund 805-6556194744

Reported by SOFINNOVA INVESTMENTS, INC. (CRD 160297).

Annual Updating Amendment for Registered Adviser · fiscal year 2025.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Sofinnova Bio Equities Gp Llc	Executive
Sofinnova Investments, Inc.	Executive
Sofinnova Ventures, Inc.	Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

3000 Sand Hill Road Building 3, Suite 150
Menlo Park, CA, 94025
Phone: 650-681-8482